UBIVAC

ubivac-logo

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the groundbreaking research being developed in the region.

#SimilarOrganizations #People #Website #More

UBIVAC

Social Links:

Industry:
Biotechnology Health Care Wellness

Founded:
2005-01-01

Address:
Portland, Oregon, United States

Country:
United States

Website Url:
http://www.ubivac.com

Total Employee:
1+

Status:
Active

Total Funding:
2.2 M USD

Technology used in webpage:
Viewport Meta Euro SPF Content Delivery Network IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Pound Sterling Microsoft Azure DNS


Similar Organizations

access-vc-logo

Access VC

Access VC invests in founders who fight for access to better health, hygiene & nutrition.

aravax-logo

Aravax

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

innovative-cellular-therapeutics-logo

Innovative Cellular Therapeutics

Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

navican-logo

NAVICAN

NAVICAN offers a comprehensive end-to-end solution to help both oncologists and patients.

neupharma-logo

NeuPharma

NeuPharma is a biotech company dedicated to research and development of innovative medicines.

proteas-bioanalytics-logo

Proteas Bioanalytics

Proteas Bioanalytics is a biotechnology platform intended to determine any disease from a single drop of blood.

pureform-global-logo

PureForm Global

PureForm Global is a biotechnology company that specializes in the research, development, and commercialization of CBD and cannabinoids.

not_available_image

Tanox, Inc.

Tanox, Inc. is a a biotechnology company, engages in the discovery and development of therapeutic monoclonal antibodies.

welichem-biotech-logo

Welichem Biotech

Welichem Biotech is a development stage biotechnology company, engages in the discovery and development of therapeutic drugs.

Current Employees Featured

bernard-a-fox_image

Bernard A. Fox
Bernard A. Fox Co-Founder / President / CEO @ UbiVac
Co-Founder / President / CEO
2005-01-01

bernard-a-fox_image

Bernard A. Fox
Bernard A. Fox COO @ UbiVac
COO

not_available_image

Traci L. Hilton
Traci L. Hilton VP @ UbiVac
VP

not_available_image

Steve Buhaly
Steve Buhaly CFO @ UbiVac
CFO

not_available_image

Hong-Ming Hu
Hong-Ming Hu CSO & Co-founder @ UbiVac
CSO & Co-founder

Founder


bernard-a-fox_image

Bernard A. Fox

Official Site Inspections

http://www.ubivac.com

  • Host name: 104.21.88.166
  • IP address: 104.21.88.166
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "UbiVac"

UbiVac - Crunchbase Company Profile & Funding

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. View contacts for UbiVac to access new leads and …See details»

Overview - UbiVac

UbiVac is a clinical stage immuno-oncology company that offers a pipeline of groundbreaking immunotherapies in preclinical and clinical trials.See details»

Board of Directors - UbiVac

As founder and CEO of UbiVac, he has led the company from development through first-in-human phase I/II trials and to collaborations with Janssen/JNJ, Bristol Myers Squibb, CanWell …See details»

UbiVac Company Profile | Management and Employees List

UbiVac has ongoing preclinical and discovery programs using DRibble®, nanoparticles and spread-defective Cytomegalovirus (sdCMV). Founded in Portland, Ore. in 2005, by Drs. Be …See details»

UbiVac, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore UbiVac, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, and 2 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, …See details»

UbiVac - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 14, 2022: Seed Round - …See details»

UbiVac - The Org

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the …See details»

UbiVac - Contacts, Employees, Board Members, Advisors & Alumni …

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. ... Solutions. Products. Resources. Pricing. …See details»

UbiVac Company Profile - Office Locations, Competitors, Revenue …

UbiVac is a biotechnology company developing and commercializing immunotherapy products that induce anti-cancer immunity.See details»

Bernie Fox - Chief Operating Officer - UbiVac | LinkedIn

The organization serves as a hub for over 2,500 entrepreneurs, members, forum leaders, partners, ambassadors, and global speakers, providing a platform for sharing best practices …See details»

UbiVac - Products, Competitors, Financials, Employees, …

UbiVac is a clinical-stage immunotherapy and cancer target discovery company operating in the biotechnology sector. It focuses on the research, development, and manufacture of …See details»

Executive Leadership - UbiVac

Executive Leadership . © 2020 UbiVac | All rights reserved.See details»

UbiVac - Overview, News & Similar companies | ZoomInfo.com

View UbiVac (www.ubivac.com) location in Oregon, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

UbiVac - Oregon Bioscience Association

UbiVac’s lead product, DPV-001 (DRibble) is a first in class DC-targeted complex vaccine/combination immunotherapy that is now in Phase II clinical trials for lung cancer. A …See details»

UbiVac Stock Price, Funding, Valuation, Revenue & Financial …

Jun 11, 2024 UbiVac has raised $1.79M over 6 rounds. UbiVac's latest funding round was a Debt - II for $0.15M on June 11, 2024. Date. Round. Amount. Investors. Valuation. Valuations …See details»

UbiVac Announces Collaboration with Johnson & Johnson …

Sep 29, 2015 /PRNewswire/ -- UbiVac, www.ubivac.com, a privately held clinical stage Immuno-Oncology company, ... The World Health Organization defines this as a potentially malignant …See details»

What is UbiVac? Company Culture, Mission, Values | Glassdoor

UbiVac. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free …See details»

Pipeline — UbiVac

Pipeline. UbiVac and collaborators are in various stages of research and clinical trials with a pipeline of immunotherapeutic products that include cancer vaccine technologies and cellular …See details»

FDA Grants Approval for UbiVac Manufactured Coronavirus …

Oct 29, 2020 According to the World Health Organization there are 17 vaccine trials ongoing in the USA and 44 in the world. The majority of these trials are what UbiVac considers to be trials …See details»

linkstock.net © 2022. All rights reserved